The Alethium team traveled to San Francisco for the 16th annual Outsourcing in Clinical Trials West Coast in February where industry minds converged on operational challenges and technological advancements in clinical trials in 2024. Discussions at OCT revolved around updated regulations, generative AI, strategies for accelerated global clinical development, and participant engagement.

At Alethium, we’re proud to play a key role in advancing clinical trials – especially those facing unique obstacles and complexities. Through our robust digital platform, we provide precision-built eConsent, seamless integrations, eCOAs, televisits and unlimited scalability for complex global trials, all without additional costs or scheduling disruptions.

We appreciate everyone who contributed their insights and 2024 projections at OCT West.